These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 30243114)

  • 21. Lipid profiling of lipoproteins by electrospray ionization tandem mass spectrometry.
    Scherer M; Böttcher A; Liebisch G
    Biochim Biophys Acta; 2011 Nov; 1811(11):918-24. PubMed ID: 21745591
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aging-related lipidomic changes in mouse serum, kidney, and heart by nanoflow ultrahigh-performance liquid chromatography-tandem mass spectrometry.
    Eum JY; Lee JC; Yi SS; Kim IY; Seong JK; Moon MH
    J Chromatogr A; 2020 May; 1618():460849. PubMed ID: 31928769
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lipidomic analysis of plasma, erythrocytes and lipoprotein fractions of cardiovascular disease patients using UHPLC/MS, MALDI-MS and multivariate data analysis.
    Holčapek M; Červená B; Cífková E; Lísa M; Chagovets V; Vostálová J; Bancířová M; Galuszka J; Hill M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2015 May; 990():52-63. PubMed ID: 25855318
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma Lipidome Analysis by Liquid Chromatography-High Resolution Mass Spectrometry and Ion Mobility of Hypertriglyceridemic Patients on Extended-Release Nicotinic Acid: a Pilot Study.
    Ferchaud-Roucher V; Croyal M; Moyon T; Zair Y; Krempf M; Ouguerram K
    Cardiovasc Drugs Ther; 2017 Jun; 31(3):269-279. PubMed ID: 28752209
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lipoprotein-associated phospholipase A(2) (Lp-PLA(2)) in acute coronary syndrome: relationship with low-density lipoprotein cholesterol.
    Jabor B; Choi H; Ruel I; Hafiane A; Mourad W; Genest J
    Can J Cardiol; 2013 Dec; 29(12):1679-86. PubMed ID: 24267807
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Myeloperoxidase level and inflammatory markers and lipid and lipoprotein parameters in stable coronary artery disease.
    Kimak E; Zięba B; Duma D; Solski J
    Lipids Health Dis; 2018 Apr; 17(1):71. PubMed ID: 29618370
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of urinary methylated nucleosides of patients with coronary artery disease by high-performance liquid chromatography/electrospray ionization tandem mass spectrometry.
    Li Y; Yu H; Zhao W; Xu X; Zhou J; Xu M; Gao W; Yuan G
    Rapid Commun Mass Spectrom; 2014 Oct; 28(19):2054-8. PubMed ID: 25156594
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma lipid profile comparison of five different cancers by nanoflow ultrahigh performance liquid chromatography-tandem mass spectrometry.
    Lee GB; Lee JC; Moon MH
    Anal Chim Acta; 2019 Jul; 1063():117-126. PubMed ID: 30967175
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Measurement of oxidized lipoprotein (a) in patients with acute coronary syndromes and stable coronary artery disease by 2 ELISAs: using different capture antibody against oxidized lipoprotein (a) or oxidized LDL.
    Wang JJ; Han AZ; Meng Y; Gong JB; Zhang CN; Li K; Liu YX
    Clin Biochem; 2010 Apr; 43(6):571-5. PubMed ID: 20060390
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Determination of nonpolar and polar lipid classes in human plasma, erythrocytes and plasma lipoprotein fractions using ultrahigh-performance liquid chromatography-mass spectrometry.
    Holčapek M; Cífková E; Červená B; Lísa M; Vostálová J; Galuszka J
    J Chromatogr A; 2015 Jan; 1377():85-91. PubMed ID: 25543301
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lipid profiling of FPLC-separated lipoprotein fractions by electrospray ionization tandem mass spectrometry.
    Wiesner P; Leidl K; Boettcher A; Schmitz G; Liebisch G
    J Lipid Res; 2009 Mar; 50(3):574-585. PubMed ID: 18832345
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma vaspin concentrations are decreased in acute coronary syndrome, but unchanged in patients without coronary lesions.
    Zhang B; Peng W; Li H; Lu Y; Zhuang J; Wang K; Su Y; Xu Y
    Clin Biochem; 2013 Oct; 46(15):1520-5. PubMed ID: 23850850
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lipid alterations in the skeletal muscle tissues of mice after weight regain by feeding a high-fat diet using nanoflow ultrahigh performance liquid chromatography-tandem mass spectrometry.
    Eum JY; Lee GB; Yi SS; Kim IY; Seong JK; Moon MH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Mar; 1141():122022. PubMed ID: 32062368
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improvement of lipoprotein separation with a guard channel prior to asymmetrical flow field-flow fractionation using fluorescence detection.
    Lee JY; Choi D; Johan C; Moon MH
    J Chromatogr A; 2011 Jul; 1218(27):4144-8. PubMed ID: 21193199
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lipoprotein particle profiles compared with standard lipids in association with coronary artery calcification in the general Japanese population.
    Hisamatsu T; Fujiyoshi A; Miura K; Ohkubo T; Kadota A; Kadowaki S; Kadowaki T; Yamamoto T; Miyagawa N; Zaid M; Torii S; Takashima N; Murakami Y; Okamura T; Horie M; Ueshima H;
    Atherosclerosis; 2014 Oct; 236(2):237-43. PubMed ID: 25105580
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantitative lipidomic analysis of plasma and plasma lipoproteins using MALDI-TOF mass spectrometry.
    Serna J; García-Seisdedos D; Alcázar A; Lasunción MÁ; Busto R; Pastor Ó
    Chem Phys Lipids; 2015 Jul; 189():7-18. PubMed ID: 26004846
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Retention behavior of lipids in reversed-phase ultrahigh-performance liquid chromatography-electrospray ionization mass spectrometry.
    Ovčačíková M; Lísa M; Cífková E; Holčapek M
    J Chromatogr A; 2016 Jun; 1450():76-85. PubMed ID: 27179677
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alteration of relation of atherogenic lipoprotein cholesterol to apolipoprotein B by intensive statin therapy in patients with acute coronary syndrome (from the Limiting UNdertreatment of lipids in ACS With Rosuvastatin [LUNAR] Trial).
    Ballantyne CM; Pitt B; Loscalzo J; Cain VA; Raichlen JS
    Am J Cardiol; 2013 Feb; 111(4):506-9. PubMed ID: 23237107
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The anti-oxidative capacity of high-density lipoprotein is reduced in acute coronary syndrome but not in stable coronary artery disease.
    Patel PJ; Khera AV; Jafri K; Wilensky RL; Rader DJ
    J Am Coll Cardiol; 2011 Nov; 58(20):2068-75. PubMed ID: 22051328
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relative Quantification of Phospholipids Based on Isotope-Labeled Methylation by Nanoflow Ultrahigh Performance Liquid Chromatography-Tandem Mass Spectrometry: Enhancement in Cardiolipin Profiling.
    Lee JC; Byeon SK; Moon MH
    Anal Chem; 2017 May; 89(9):4969-4977. PubMed ID: 28399627
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.